Lumida
/AKBTY
⌘K
Akbank TAS

Akbank TAS

AKBTY
$2.95USD+0.34%+0.01 today

MARKET CAP

95.6B

P/E (TTM)

0.2x

FWD P/E

0.1x

DAY RANGE

$3 – $3

52W RANGE

$2
$4

AI Summary

Stalk
Sell NowMedium

AKBTY is entrenched in a bearish regime across all horizons, with price below declining EMAs and the 200-day SMA and a series of lower highs and lows. The recent uptick has stalled at the $2.94–$3.00 resistance zone, reinforcing the likelihood of a resumption of the downtrend toward $2.78 and lower. Given the rejection at overhead moving averages and lack of exhaustion signals, immediate bearish execution at the resistance area is favored.

  • Net income climbed 38% YoY to 34.3 B TL; revenue rose 45% to 140.3 B TL
  • Digital transformation with AI-driven advisory boosts customer engagement
  • Regulatory caps on FX loans may restrict loan-book expansion
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Akbank T.A.S. (BIST: AKBNK) is a leading Turkish bank focused on delivering a comprehensive suite of banking and financial services, encompassing both retail and corporate banking segments. As one of Turkey's most established financial institutions, Akbank operates in a competitive landscape, leveraging its strong customer franchise and digital innovation to navigate macroeconomic complexities while enhancing operational efficiency. The bank's focus on risk-adjusted returns, along with its strategic investment in technology and digital solutions, positions it well for sustained growth amid a challenging economic environment.

Bull says

  • Net income climbed 38% YoY to 34.3 B TL; revenue rose 45% to 140.3 B TL
  • Digital transformation with AI-driven advisory boosts customer engagement
  • Dividend yield of 1.95% underscores strong cash-return capacity
  • Total capital ratio at 16.4% and Tier 1 ratio at 13.3% support stability
  • Targets >30% TL loan growth for disciplined, risk-adjusted expansion
  • Low leverage risk and robust profitability factors underpin resilience

Bear says

  • Regulatory caps on FX loans may restrict loan-book expansion
  • ROE guidance lowered to 23–25% amid persistent high funding costs
  • NIM outlook trimmed to 3.2–3.5%, delaying margin recovery
  • OPEX rose 37% YoY, pressuring cost efficiency
  • Negative earnings yield raises valuation concerns
  • Marginally negative revisions and liquidity factors add funding risks

Investment themes with AKBTY

Turkey +0.20%

Emerging market growth at Eurasian crossroads

TUR · TKGBY · KHOLY

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 08-11-2026bullish

Transcript signals

Bull points

  • our net income was up by 35% year-on-year to $57,224,000,000, resulting in an ROE of 21.5% and an ROA of 1.9% for the full year.
  • During the same period, we achieved solid revenue growth, up by 50% year on year to $222 billion and $33 million, thanks to robust fee income generation and NII building momentum in the second half of the year.
  • Our quarterly net income was up by 30% to $18,317,000,000, leading for our quarterly ROE to show a sequential improvement to 24.9%, up from 21% in the third quarter.
Read full transcript analysis ›